While We strive to use commercially acceptable means to protect Your Personal Data, We cannot guarantee its absolute security
doi: 10.3389/fnut.2026.1794882 Received 23 January 2026 Revised 02 March 2026 Accepted 02 March 2026 Published 24 March 2026 Volume 13 - 2026 Edited by Amin Gasmi, Francophone Society of Nutritherapy and Applied Nutrigenetics, France Reviewed by Meryem Saban Gler, Batman University, Trkiye Updates Copyright 2026 Cengiz Kaynakc
Mounjaro (tirzepatide) UK Summary of Product Characteristics
[1] Important: Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The 3-month mark serves as a reliable predictor of long-term success, making persistence through the adaptation phase even more valuable
By leading conversations around mindful eating, nutrient optimisation and the intersection of food and pharmaceuticals, you can create meaningful connections with GLP-1 users
